Accessibility StatementSkip Navigation DUBLIN, Dec. 1, 2025 /PRNewswire/ --Â Edmund Reese, Chief Financial Officer of Aon plc (NYSE: AON), a leading global professional services firm, will speak at the Goldman Sachs U.S. Financial Services Conference in New York on Wednesday, December 10, in a session that begins at 1:00 PM ET. A live webcast will be available on the day of the conference via Aon's Investor Relations website at ir.aon.com. A replay will be available on the same website, shortly after the ev ...

Core Viewpoint - BofA Securities initiated coverage on WeRide Inc. with a Buy rating and a price target of $12 per ADR [1] Group 1: Company Overview - WeRide is described as an emerging global provider of Level 4 autonomous-driving solutions [2] - The company is projected to significantly expand its fleet and achieve profitability by 2029 [2] Group 2: Growth Catalysts - Key catalysts for growth include a broader international rollout of robotaxi operations supported by strategic partnerships and first-mover advantages [2] - Improved profitability in China is expected as the company scales its operations [2] - Accelerated adoption of WeRide's robobus, robovan, and robosweeper offerings is anticipated, all integrated within the WeRide One platform [2] Group 3: Valuation Methodology - BofA's price target of $12 per ADR is based on an average of price-to-sales (P/S) and discounted cash flow (DCF) valuation methodologies [3] - The equivalent target for Hong Kong-listed shares is HKD 31 [3]

Key Takeaways ALL, TEF, ENS and CMC surface as low-PEG value stocks meeting strict screening criteria.Each pick pairs a discounted valuation with solid growth metrics and a strong Style Score.ALL, TEF, ENS and CMC also show rising earnings estimates and meet volume and size thresholds. At a time when volatility strikes every second day, investors often rely on value investing rather than other options like growth or momentum. As soon as other investors start selling their stocks at a cheaper rate in times o ...

Key Takeaways AI demand lifts PLTR as soaring AIP adoption and a higher revenue outlook highlight accelerating growth.PLTR's AIP drives sharp Q3 growth, with U.S. commercial revenues up 121% year over year to $397 million.MU boosts guidance on strong HBM chip demand, pushing fiscal Q4 revenues to $11.32B and FY25 to $37.38B.The artificial intelligence (AI) boom helped NVIDIA Corporation (NVDA) become the most valuable company, with a market capitalization of $4.3 trillion. Major tech firms are increasingly ...

Approval underscores Amneal’s advanced sterile manufacturing capabilities and expansion within complex ophthalmic therapies; Launch expected in Q1 2026  BRIDGEWATER, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (NASDAQ: AMRX) today announced the U.S. Food and Drug Administration (FDA) has approved the Company’s cyclosporine ophthalmic emulsion 0.05%, a sterile, preservative-free formulation supplied in single-use vials. The product is the generic equivalen ...

BOSTON, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a leader in threat detection and exposure management, today announced that the company will be attending the Raymond James TMT and Consumer Conference in New York, NY. The presentation is scheduled for Monday, December 8, 2025 at 3:40 p.m. Eastern Time. The presentation will be webcast live, and a replay will be available for a limited time, under the “Events and Presentations” section on the company’s investor relations website at invest ...

WILMINGTON, N.C., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Live Oak Bancshares announced today that Ewa M. Stasiowska has been named Chief Risk Officer (CRO) of the company. Stasiowska also assumes the role of CRO of Live Oak Bank. Stasiowska is a senior risk management executive with more than two decades of experience overseeing enterprise, financial, operational, and model risk functions within regulated financial institutions. Previously, she was Senior Managing Director at Webster Bank, where she was responsi ...

ATLANTA, GA, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (the “Company”, “Regional”, “we”, “us” or “our”) (OTCQB: RHEP) (OTCQB: RHEPA) (OTCQB: RHEPB) (OTCQB:RHEPZ), today announced that its Board of Directors authorized and approved the purchase of up to an aggregate of 500,000 shares of Series B Preferred Stock (“Stock Repurchase Plan”) . The Special Committee of the Company’s Board of Directors is authorized to oversee the timing, nature, amount and conduct of the Stock Repurchase P ...

What is the class period? October 22, 2024 - October 28, 2025 What is the case about? Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Stride during the class period because the Company allegedly misled investors regarding its fraudulent and deceptive business practices.  For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What are the allegations? According to the compla ...

Core Viewpoint - UBS has raised its price target on Macy's to $7.00 from $6.50 while maintaining a Sell rating [1] Group 1: Earnings Forecast - UBS's recent channel checks indicated stronger-than-expected third-quarter sales trends, prompting an increase in Q3 earnings forecast by $0.18 to a loss of $0.12 per share, with an expectation of an EPS beat of $0.03 [2] - Despite the improved quarterly outlook, Macy's is likely to reaffirm its fiscal 2025 guidance due to ongoing uncertainties related to tariffs and macroeconomic conditions [2] Group 2: Market Expectations - The market seems to anticipate a similar stance from Macy's management, which reduces the likelihood of significant revisions to consensus estimates or major movements in the stock's valuation multiple following the earnings report [3] - There is potential upside if Macy's provides more positive commentary on early fourth-quarter trends, but elevated bullish sentiment could turn the Q3 release into a "market-clearing event" [3] - The options market is pricing in a ±10.5% move on earnings, which is higher than Macy's historical average of 7.8%, indicating expectations for increased post-print volatility [3]